Dr. Michael L. McGrattan, MD

Dr. McGrattan practices at Cayuga Medical Center in Ithaca, New York, part of Centralus Health.

Dr. McGrattan's NPI, 1366885634, was assigned on April 16, 2013. Dr. McGrattan holds New York license 295129.

Dr. McGrattan's primary practice is Cayuga Medical Center, at 101 Dates Drive, Ithaca, NY 14850 in Tompkins County. The practice phone is (607) 274-4401.

Dr. McGrattan's primary practice is Cayuga Medical Center in Ithaca, New York, part of Centralus Health. Dr. McGrattan is also affiliated with Upstate University Hospital. The medical group on file is Cayuga Medical Associates. Dmand AI also links Dr. McGrattan to 1 more hospital, 2 medical groups and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGrattan practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. McGrattan's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. McGrattan is licensed in New York.

CMS data shows 70 Medicare services from Dr. McGrattan across 2 procedure codes in 2023, all of them office visits, for 84 Medicare patients. Medicare paid $3,600 for them.

CMS counts 84 Medicare patients who saw Dr. McGrattan in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McGrattan's median patient age at 57, with 45% women.

In 2024, Dr. McGrattan wrote 26 Medicare Part D claims for 17 patients. 92% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $93 in total drug cost. In 2020, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. McGrattan for performance year 2024, reported through an alternative payment model (APM). Dr. McGrattan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McGrattan as offering telehealth. CMS counts 82 procedures of removal of tissue by Dr. McGrattan, more than 83% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. McGrattan, published from 2012 to 2015. 2015 was the busiest year, with 2. The most frequent topics are Biomechanical Phenomena, Cadaver and Forearm. Dr. McGrattan has published most often in J Hand Surg Am. Dr. McGrattan's most frequent co-authors are Brian J. Harley, MD and Walter H. Short, MD.

CMS Open Payments shows 36 general payments to Dr. McGrattan from 14 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 86% of the total. Medtronic Vascular, Inc. paid the most, $260.